Distinct mechanisms of B and T lymphocyte accumulation generate tumor-draining lymph node hypertrophy
Authors:
Open Access
- 13 May 2016
- journal article
- research article
- Published by Taylor & Francis in OncoImmunology
- Vol. 5 (8) , e1204505
Abstract
Tumor-draining lymph nodes (TDLNs) often enlarge in human cancer patients and in murine tumor models, due to lymphocyte accumulation and lymphatic sinus growth. B lymphocytes within TDLNs can drive lymph node hypertrophy in response to tumor growth, however little is known about the mechanisms directing the preferential accumulation of B lymphocytes relative to T cells in enlarging TDLNs. To define why B and T lymphocytes accumulate in TDLNs, we quantified lymphocyte proliferation, apoptosis, entry, and exit in TDLNs versus contralateral non-TDLNs (NTDLNs) in a footpad B16-F10 melanoma mouse model. B and T lymphocyte proliferation and apoptosis were increased as the TDLNs enlarged, although relative rates were similar to those of NTDLNs. TDLN entry of B and T lymphocytes via high endothelial venules was also modestly increased in enlarged TDLNs. Strikingly, the egress of B cells was strongly reduced in TDLNs versus NTDLNs, while T cell egress was modestly decreased, indicating that regulation of lymphocyte exit from TDLNs is a major mechanism of preferential B lymphocyte accumulation. Surface sphingosine-1-phosphate receptor 1 (S1PR1) which binds S1P and signals lymphocyte egress, exhibited greater downregulation in B relative to T lymphocytes, consistent with preferential retention of B lymphocytes in TDLNs. TDLN lymphocytes did not activate surface CD69 expression, indicating a CD69-independent mechanism of downregulation of S1PR1. B and T cell trafficking via afferent lymphatics to enter TDLNs also increased, suggesting a pathway for accumulation of tumor-educated lymphocytes in TDLNs. These mechanisms regulating TDLN hypertrophy could provide new targets to manipulate lymphocyte responses to cancer.Keywords
This publication has 79 references indexed in Scilit:
- CXCR4 and a cell-extrinsic mechanism control immature B lymphocyte egress from bone marrowJournal of Experimental Medicine, 2014
- Sphingosine-1-Phosphate and Lymphocyte Egress from Lymphoid OrgansAnnual Review of Immunology, 2012
- B Lymphocytes Promote Lymphogenous Metastasis of Lymphoma and MelanomaNeoplasia, 2011
- Extralymphatic Tumors Prepare Draining Lymph Nodes to Invasion via a T-Cell Cross-Tolerance ProcessCancer Research, 2007
- T‐cell migration: a naive paradigm?Immunology, 2007
- Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.2006
- Homing of antibody secreting cellsImmunological Reviews, 2003
- Balanced responsiveness to chemoattractants from adjacent zones determines B-cell positionNature, 2002
- Proliferative patterns of lymphocytes in lymph nodes during tumour development: Involvement of T and B cell areasBritish Journal of Cancer, 1984
- THE ORIGIN OF THE CELLS IN THE EFFERENT LYMPH FROM A SINGLE LYMPH NODEJournal of Experimental Medicine, 1965